Tango Therapeutics, Inc.
USD28.56
+0.92 (+3.33%)
CEO
Malte Peters
IPO Date
2020-09-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$27.45
Prev. Close
$27.64
Day Low
$27.14
Day High
$29.71
52W Low
$5.77
52W High
$34.39
Market Cap
$3.55B
Volume
2.27M
| 19,629 |
| $29.34 |
| 2 Jul 2026 | Crystal Adam | President, R&D | S-Sale | Disposed | 7,371 | $30.25 |
| 2 Jul 2026 | Crystal Adam | President, R&D | M-Exempt | Disposed | 27,000 | $5.20 |
| 23 Jun 2026 | Azelby Robert | director | A-Award | Acquired | 5,740 | $0.00 |
| 23 Jun 2026 | Azelby Robert | director | A-Award | Acquired | 35,910 | $27.97 |
| 23 Jun 2026 | Azelby Robert | — | Disposed | 0 | $0.00 |
| 8 Jun 2026 | Ketchum John B | director | A-Award | Acquired | 4,000 | $0.00 |
| 8 Jun 2026 | Ketchum John B | director | A-Award | Acquired | 25,000 | $20.22 |
| 8 Jun 2026 | Calhoun Lesley Ann | director | A-Award | Acquired | 4,000 | $0.00 |